More about

Remission

News
September 03, 2024
2 min read
Save

Filgotinib maintains remission, improves quality of life over 4 years in UC

Filgotinib maintains remission, improves quality of life over 4 years in UC

Long-term filgotinib induced and maintained symptomatic remission and improved health-related quality of life in ulcerative colitis, with no new safety signals reported, according to interim analysis of the SELECTION extension study.

Clinical Guidance
Ulcerative Colitis
Assessment and Treatment

Disease Management Based on Clinical Severity

Gary R. Lichtenstein, MD, FACP, FACG, AGA; Robert B Stein, MD

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

News
August 14, 2024
3 min read
Save

Asthma remission appears possible with treatment

Asthma remission appears possible with treatment

SAN ANTONIO — Clinicians and researchers are beginning to explore whether asthma remission is possible, Corinne Young, FNP-C, FCCP, said during her presentation at the 16th Annual Allergy, Asthma & Immunology CME Conference.

News
July 30, 2024
1 min read
Save

Multistage revision TKA for chronic PJI may yield high remission rates, low mortality

Multistage revision TKA for chronic PJI may yield high remission rates, low mortality

For patients with chronic periprosthetic joint infection, multistage revision total knee arthroplasty procedures were associated with high remission rates and low mortality at minimum 5-year follow-up, according to published results.

Clinical Guidance
Rheumatoid Arthritis
Overview

Outcomes

John J. Cush, MD; Michael E. Weinblatt, MD; Arthur Kavanaugh, MD

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

Clinical Guidance
Lupus
Treatment Options

Treatment Approach in Systemic Lupus Erythematosus

Irene Blanco, MD, MS

This section covers the individual pharmacotherapeutic options for SLE, including their appropriate uses in SLE and the efficacy and safety data supporting their use.

News
June 14, 2024
2 min read
Save

Pegloticase ‘effectively and expeditiously’ leads 47% of gout patients into remission

Pegloticase ‘effectively and expeditiously’ leads 47% of gout patients into remission

Nearly half of patients with gout achieved remission with pegloticase treatment by 52 weeks, indicating longer-term benefits for intensive urate-lowering therapy, according to data presented at EULAR 2024 Congress.

News
June 04, 2024
2 min read
Save

Childhood lupus remission definitions emphasize corticosteroid cessation

Childhood lupus remission definitions emphasize corticosteroid cessation

New definitions of remission specific to childhood systemic lupus erythematosus promote cessation of corticosteroids and could enable combined child-adult treat-to-target studies, according to an analysis published in Clinical Immunology.

News
May 22, 2024
3 min read
Save

Documentation of asthma remission endpoints varies

Documentation of asthma remission endpoints varies

SAN DIEGO — Few patients are evaluated based on all seven endpoints of guidelines indicating complete asthma remission, according to a poster presented at the American Thoracic Society International Meeting.

News
May 10, 2024
2 min read
Save

Tocilizumab taper 'reasonable' in giant cell arteritis remission despite flare risk

Tocilizumab taper 'reasonable' in giant cell arteritis remission despite flare risk

DESTIN, Fla. — Rheumatologists should consider tapering tocilizumab for patients with giant cell arteritis in remission despite the increased risk for flare, said a speaker at the Congress of Clinical Rheumatology East annual meeting.

View more